Corticotropin-releasing hormone (CRH) is
Introduction
Corticotropin-releasing hormone (CRH) and its receptors are widely expressed in the brain and peripheral tissues. [1] [2] [3] This hormone is the principal regulator of the hypothalamic-pituitary-adrenal (HPA) axis 2 and exerts its effects via two main receptor subtypes, type 1 (CRH-R1) 3 and 2 (CRH-R2). 4 CRH also activates both the adrenomedullary and systemic sympathetic system limbs and an intraadrenal CRH/ACTH/cortisol system has been postulated. 5 Recently, the CRH-R1 has been demonstrated in mid-gestation human fetal adrenals and CRH has been shown to stimulate directly adrenal steroidogenesis in human fetal adrenal cells via the phospholipase C-inositol phosphate second messenger system. 6, 7 Since several mental disorders, including melancholic depression, 8 anxiety disorders, 9,10 and Alzheimer's disease, 8 are associated with hyperactivation of the HPA axis and the sympathetic system, it is of major interest to identify substances which selectively inhibit the activity of these systems. Because of its chemical structure, its oral actions, and its ability to cross the blood-brain barrier, the novel CRH-R1 antagonist antalarmin holds promise in the treatment of disorders associated with an increased CRH drive. [11] [12] [13] This is the first study to examine the direct effect of the CRH-R1 antagonist antalarmin on human adrenal cortical and/or medullary cells in vitro.
Materials and methods

Materials
Normal human adrenal glands (n = 4) were surgically removed along with one kidney for renal carcinoma. Excised tissues were transferred to prechilled phosphate-buffered saline, pH 7.6, and kept on ice until Molecular Psychiatry further treatment. In addition, the human adrenocortical cell line NCI-H295 was employed to test the effects of antalarmin on cortisol secretion of pure adrenocortical cells.
Immunohistology
Adrenocortical and chromaffin cells were characterized by single and double immunohistochemistry using paraffin-embedded tissue samples and cultured cells. The labelled streptavidin-biotin-peroxidase reaction (DAKO, Hamburg, Germany) was combined with the DAB chromogen and the peroxidase-anti-peroxidase method (DAKO) with the AEC chromogen. Cortical cells were identified with a specific rabbit antibody to 17-alpha hydroxylase (courtesy of MR Waterman, Nashville, USA) and chromaffin cells with a specific monoclonal mouse antibody to chromogranin A (DAKO) as described previously. 14, 15 Reverse-transcription PCR Human adrenal mRNA (1 g) which was purchased from Clontech (Palo Alto, CA, USA) was reversely transcribed to cDNA in a first step according to the instructions of the first strand cDNA synthesis kit (Roche Diagnostics, Mannheim, Germany). For PCR amplification, we used the CRH, CRH-R1, and CRH-R2 primers listed in Table 1 , and applied the conditions as follows: 40 thermal step cycles of denaturation at 94°C for 1 min, annealing at 60°C for 1 min, and elongation at 72°C for 2 min. For the ACTH primer, all conditions were identical except for the annealing temperature, which was 55°C. For positive control, we used mRNA from pituitary gland (Clontech). For negative control, we amplified preparations skipping the RT step.
Co-culture system
For in vitro studies adrenal tissue was mechanically dissected and enzymatically digested. Both medullary and cortical cells were dispersed in culture wells as described previously. 14, 15 Briefly, after 3 days of undisturbed growth, cells were washed and subjected to incubation with CRH (10 
Results
Cortical and chromaffin cells were interwoven to a great degree in human adrenal glands as visualized by double immunohistochemistry (Figure 1a ). In the coculture system, human adrenocortical cells showed a positive staining signal for anti-17-alpha hydroxylase immunoglobulin and were documented to be in direct contact with adrenomedullary cells (Figure 1b) . Intraadrenal CRH (122-bp fragment) and ACTH (77-bp fragment) mRNA were found to be expressed as evidenced by RT-PCR (Figure 2a 
Discussion
This is the first study to examine the effect of antalarmin, a novel CRH-R1 antagonist, on human adrenal tissue using an in vitro culture system. Whereas the ACTH-mediated rise in cortisol secretion from normal human adrenal cells was not affected, stimulation of cortisol secretion by CRH was completely reversed by co-incubation with this compound. In addition, we demonstrated the expression of ACTH, CRH, and both CRH-R1 and CRH-R2 mRNAs in the adult human adrenal. These findings support the hypothesis of the existence of an intraadrenal CRH system. 5, 17 Within the adrenal itself, CRH-like immunoreactivity has been detected in the medulla of humans and other species. 18, 19 This adrenal CRH is identical to the hypothalamic CRH and is released in response to physiological stimuli such as hemorrhage, 20 splanchnic nerve activation, 21, 22 K + -induced depolarization, nicotine, 23 and various neuropeptides and cytokines. 24, 25 Like the central CRH/ACTH system, the peripheral adrenal CRH/ACTH system is regulated via feedback mechMolecular Psychiatry anisms. Thus, while cortisol treatment lowered adrenal CRH content after 7 days, 26 the intraadrenal content of CRH and ACTH immunoreactivity increased in hypophysectomized rats. 27 A complete CRH/ACTH system exists within the human adrenal with the adrenal medulla as a source of CRH and adrenal medullary chromaffin cells as the target for this local releasing hormone and the source of ACTH. It is possible that the adrenal CRH/ACTH system is important in the overall function and fine-tuning of the gland. Certainly the close morphological relationship of cortical and chromaffin tissue is crucial for this system. 28 Chromaffin and cortical cells were found to be in direct cellular contact in our in vitro co-culture system, which also reflected the close anatomical co-localization of the two endocrine cell types in the adrenal in situ. Therefore, since chromaffin cells produce POMCderived peptides, including ACTH as well as other cortisol secretagogues 17 and respond to stimulation with CRH, we assume that exposure of chromaffin cells to CRH directly leads to secretion of ACTH with subsequent stimulation of steroidogenesis by adrenocortical cells in a paracrine manner.
Two major subtypes of the CRH receptors (CRH-R1, CRH-R2) have been identified, cloned, and characterized in terms of their pharmacological specificity and regional localization. [29] [30] [31] [32] [33] [34] [35] CRH-R1 receptors are most abundant in neocortical, cerebellar, and sensory relay structures, while CRH-R2 receptors are predominantly localized in specific subcortical areas and peripheral tissues. 3 Antalarmin effectively displaces 125 ovine CRH binding in tissues expressing CRH-R1 but not in tissues expressing CRH-R2, and therefore is a specific CRH-R1 receptor antagonist.
The complete inhibition of the CRH-mediated response by antalarmin, a specific CRH-R1 receptor antagonist, and the molecular evidence for CRH-R1 expression in adult human adrenal tissue establishes the involvement of this receptor in the intraadrenal CRH/ACTH/cortisol system. In addition, the presence of CRH-R1 receptors on immune cells and the documented steroidogenic action of immune mediators such as interleukin-1 5, 36 and interleukin-6, 37,38 also suggest an intraadrenal paracrine CRH/immune peptide axis which may contribute to the increase in cortisol production by adrenocortical cells as well. Participation of the CRH-R1 in intraadrenal cortisol regulation, in the process of inflammation, 39, 40 and in the syndrome of ectopic CRH production seem to justify clinical trials in pathologic states with the above mentioned conditions.
